Sign Up to like & get
recommendations!
0
Published in 2022 at "Chinese Medical Journal"
DOI: 10.1097/cm9.0000000000002508
Abstract: Abstract Background: The pharmacokinetic and clinical behaviors of many proton pump inhibitors (PPIs) in peptic ulcer treatment are altered by CYP2C19 genetic polymorphisms. This non-inferiority study evaluated the efficacy and safety of the novel PPI…
read more here.
Keywords:
safety;
duodenal ulcers;
rabeprazole;
non inferiority ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2023 at "Caspian Journal of Internal Medicine"
DOI: 10.22088/cjim.14.2.179
Abstract: Background: Helicobacter pylori infection is the most common cause of peptic ulcer disease. However, the prevalence rates of non-helicobacter pylori idiopathic peptic ulcers have increased over the past few years. This study aims to compare…
read more here.
Keywords:
helicobacter pylori;
pylori positive;
positive ulcers;
duodenal ulcers ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2021.690995
Abstract: Background: Proton pump inhibitors (PPIs) are validated gastric acid suppressors and have been widely used to treat patients with active duodenal ulcers. Although existing PPIs have shown great efficacy, many scientists are still devoted to…
read more here.
Keywords:
duodenal ulcers;
clinical trial;
anaprazole;
safety ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Frontiers in Pediatrics"
DOI: 10.3389/fped.2019.00547
Abstract: Objective: To evaluate the diagnostic utility of wall hypertrophy of the duodenal bulb with a hyperechoic lumen, designated as the “HH sign,” using ultrasound sonography (US) in pediatric duodenal ulcer (DU) patients. Study design: We…
read more here.
Keywords:
duodenal ulcers;
utility ultrasonography;
utility;
sign ... See more keywords